Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023
16 February 2023 - 11:30PM
Business Wire
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”),
the manufacturer of a proprietary helium plasma and radiofrequency
technology marketed and sold as Renuvion®, today announced that
financial results for the fourth quarter and fiscal year 2022 will
be released before the market opens on Thursday, March 16th.
Management will host a conference call at 8:00 a.m. Eastern Time
on March 16th to discuss the results of the quarter and year, and
to host a question and answer session. To listen to the call by
phone, interested parties may dial 877-407-8289 (or 201-689-8341
for international callers) and provide access code 13736530.
Participants should ask for the Apyx Medical Corporation Call. A
live webcast of the call will be accessible via the Investor
Relations section of the Company’s website and at:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=RDPQw6xg.
A telephonic replay will be available approximately two hours
through the following two weeks. The replay can be accessed by
dialing 877-660-6853 for U.S. callers or 201-612-7415 for
international callers and using the replay access code: 13736530.
The webcast will be archived on the Investor Relations section of
the Company’s website.
About Apyx Medical
Corporation:
Apyx Medical Corporation is an advanced energy technology
company with a passion for elevating people’s lives through
innovative products, including its Helium Plasma Technology
products marketed and sold as Renuvion in the cosmetic surgery
market and J-Plasma® in the hospital surgical market. Renuvion and
J-Plasma offer surgeons a unique ability to provide controlled heat
to tissue to achieve their desired results. The Company also
leverages its deep expertise and decades of experience in unique
waveforms through OEM agreements with other medical device
manufacturers. For further information about the Company and its
products, please refer to the Apyx Medical Corporation website at
www.ApyxMedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230216005500/en/
Investor Relations:
ICR Westwicke on behalf of Apyx Medical Corporation Mike
Piccinino, CFA investor.relations@apyxmedical.com
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From May 2023 to Jun 2023
Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Jun 2022 to Jun 2023